• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有潜力成为癌症预后的生物标志物:一项泛癌分析。

has potential to be a biomarker for cancer prognosis: A pan-cancer analysis.

作者信息

Yuan Ziming, Zhong Yuchen, Hu Hanqing, Zhang Weiyuan, Wang Guiyu

机构信息

Cancer Center/Department of Colorectal Cancer Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

出版信息

Front Oncol. 2023 Jan 4;12:1064376. doi: 10.3389/fonc.2022.1064376. eCollection 2022.

DOI:10.3389/fonc.2022.1064376
PMID:36686789
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9848736/
Abstract

INTRODUCTION

is a gene associated with the immune system and is thought to play a crucial role in autoimmunity. There are few -related studies in cancer, and it is assumed that is a proto-oncogene. There is currently no pan-cancer analysis of , and we performed a systematic and comprehensive pan-cancer analysis of in an attempt to reveal its role and function in cancer.

METHODS

The data were analyzed by mining databases available to the public and by using R software. Moreover, immunohistochemistry was used to validate the results.

RESULTS

Our results revealed that is commonly aberrantly expressed in cancer and its expression is strongly correlated with survival prognosis in a variety of cancer types. Through correlation analysis we found that was associated with multiple immune genes and was closely related to immune infiltration. In the enrichment analysis, may have cross-talk with multiple cancer pathways and exert oncogenic or pro-cancer functions. In addition, we collected pathological samples from colorectal cancer patients for immunohistochemical analysis and found that patients with higher immunohistochemical scores had more lymph node metastases, higher CA199, and bigger tumor size.

DISCUSSION

Overall, expression is closely related to cancers and has the potential to act as a cancer biomarker.

摘要

引言

[基因名称]是一种与免疫系统相关的基因,被认为在自身免疫中起关键作用。在癌症方面,与该基因相关的研究较少,并且推测它是一种原癌基因。目前尚无关于该基因的泛癌分析,我们进行了一项系统全面的该基因泛癌分析,试图揭示其在癌症中的作用和功能。

方法

通过挖掘公开可用的数据库并使用R软件对数据进行分析。此外,采用免疫组织化学方法验证结果。

结果

我们的结果显示,该基因在癌症中普遍异常表达,其表达与多种癌症类型的生存预后密切相关。通过相关性分析,我们发现该基因与多个免疫基因相关,并且与免疫浸润密切相关。在富集分析中,该基因可能与多种癌症通路存在相互作用,并发挥致癌或促癌功能。此外,我们收集了结直肠癌患者的病理样本进行免疫组织化学分析,发现免疫组织化学评分较高的患者有更多的淋巴结转移、更高的CA199水平和更大的肿瘤尺寸。

讨论

总体而言,该基因的表达与癌症密切相关,并且有潜力作为一种癌症生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/618a8858cc99/fonc-12-1064376-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/fcba4d0912a3/fonc-12-1064376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/50faf25c8d32/fonc-12-1064376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/07ad339f9968/fonc-12-1064376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/fee617f3b1ed/fonc-12-1064376-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/aaaf083c9927/fonc-12-1064376-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/9b29a5ec887b/fonc-12-1064376-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/ac232f426c26/fonc-12-1064376-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/bee79d1c5626/fonc-12-1064376-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/618a8858cc99/fonc-12-1064376-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/fcba4d0912a3/fonc-12-1064376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/50faf25c8d32/fonc-12-1064376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/07ad339f9968/fonc-12-1064376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/fee617f3b1ed/fonc-12-1064376-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/aaaf083c9927/fonc-12-1064376-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/9b29a5ec887b/fonc-12-1064376-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/ac232f426c26/fonc-12-1064376-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/bee79d1c5626/fonc-12-1064376-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2273/9848736/618a8858cc99/fonc-12-1064376-g009.jpg

相似文献

1
has potential to be a biomarker for cancer prognosis: A pan-cancer analysis.有潜力成为癌症预后的生物标志物:一项泛癌分析。
Front Oncol. 2023 Jan 4;12:1064376. doi: 10.3389/fonc.2022.1064376. eCollection 2022.
2
High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.DEF6 高表达水平预示着透明细胞肾细胞癌患者的预后不良。
Oncol Rep. 2020 Nov;44(5):2056-2066. doi: 10.3892/or.2020.7736. Epub 2020 Aug 18.
3
A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors.泛癌症分析表明,核苷酸还原酶亚基 M2 在人类肿瘤中具有致癌作用。
PeerJ. 2022 Nov 28;10:e14432. doi: 10.7717/peerj.14432. eCollection 2022.
4
Increased DEF6 expression is correlated with metastasis and poor prognosis in human osteosarcoma.DEF6表达增加与人类骨肉瘤的转移及不良预后相关。
Oncol Lett. 2020 Aug;20(2):1629-1640. doi: 10.3892/ol.2020.11743. Epub 2020 Jun 17.
5
Pan-Cancer Analysis of the Oncogenic and Immunological Role of A Potential Biomarker for Prognosis and Immunotherapy.一种潜在的预后和免疫治疗生物标志物的致癌和免疫作用的泛癌分析
Front Oncol. 2022 May 16;12:811567. doi: 10.3389/fonc.2022.811567. eCollection 2022.
6
Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity.综合泛癌分析证实FCGR3A是一种与肿瘤免疫相关的候选生物标志物。
Front Pharmacol. 2022 May 20;13:900699. doi: 10.3389/fphar.2022.900699. eCollection 2022.
7
FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer.FUC A2 是一种预后生物标志物,与泛癌中的免疫抑制微环境相关。
Front Immunol. 2021 Oct 20;12:758648. doi: 10.3389/fimmu.2021.758648. eCollection 2021.
8
Comprehensive pan-cancer analysis and the regulatory mechanism of AURKA, a gene associated with prognosis of ferroptosis of adrenal cortical carcinoma in the tumor micro-environment.肿瘤微环境中与肾上腺皮质癌铁死亡预后相关基因AURKA的综合泛癌分析及调控机制
Front Genet. 2023 Jan 4;13:996180. doi: 10.3389/fgene.2022.996180. eCollection 2022.
9
A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.泛癌种中肌动蛋白相关蛋白 2/3 复合物亚基 5 的全面预后和免疫分析及在肝细胞癌中的鉴定。
Front Immunol. 2022 Sep 6;13:944898. doi: 10.3389/fimmu.2022.944898. eCollection 2022.
10
Data mining-based study of collagen type III alpha 1 (COL3A1) prognostic value and immune exploration in pan-cancer.基于数据挖掘的 III 型胶原α 1 (COL3A1)在泛癌中的预后价值及其免疫探索的研究。
Bioengineered. 2021 Dec;12(1):3634-3646. doi: 10.1080/21655979.2021.1949838.

引用本文的文献

1
Contrastive sequence signatures between the both sides of a recombination spot reveal an adaptation at PPARD locus from standing variation for pleiotropy since out-of-Africa dispersal.重组位点两侧的对比序列特征揭示了自走出非洲扩散以来,PPARD基因座因多效性的现存变异而产生的一种适应性。
BMC Genomics. 2025 Apr 30;26(1):427. doi: 10.1186/s12864-025-11620-y.
2
Multi-omic analyses reveal PTPN6's impact on tumor immunity across various cancers.多组学分析揭示了PTPN6对多种癌症肿瘤免疫的影响。
Sci Rep. 2025 Apr 1;15(1):11025. doi: 10.1038/s41598-025-96302-1.

本文引用的文献

1
Different Apples, Same Tree: Visualizing Current Biological and Clinical Insights into CTLA-4 Insufficiency and LRBA and DEF6 Deficiencies.同根异果:可视化CTLA-4功能不全、LRBA和DEF6缺陷的当前生物学及临床见解
Front Pediatr. 2021 Apr 28;9:662645. doi: 10.3389/fped.2021.662645. eCollection 2021.
2
The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets.2021 年的 STRING 数据库:可定制的蛋白质-蛋白质网络,以及用户上传的基因/测量集的功能特征分析。
Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612. doi: 10.1093/nar/gkaa1074.
3
High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
DEF6 高表达水平预示着透明细胞肾细胞癌患者的预后不良。
Oncol Rep. 2020 Nov;44(5):2056-2066. doi: 10.3892/or.2020.7736. Epub 2020 Aug 18.
4
Increased DEF6 expression is correlated with metastasis and poor prognosis in human osteosarcoma.DEF6表达增加与人类骨肉瘤的转移及不良预后相关。
Oncol Lett. 2020 Aug;20(2):1629-1640. doi: 10.3892/ol.2020.11743. Epub 2020 Jun 17.
5
DEF6 deficiency, a mendelian susceptibility to EBV infection, lymphoma, and autoimmunity.DEF6缺陷,一种对EB病毒感染、淋巴瘤和自身免疫的孟德尔易感性。
J Allergy Clin Immunol. 2021 Feb;147(2):740-743.e9. doi: 10.1016/j.jaci.2020.05.052. Epub 2020 Jun 17.
6
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma.体细胞改变与免疫浸润的相互作用调节晚期透明细胞肾细胞癌对 PD-1 阻断的反应。
Nat Med. 2020 Jun;26(6):909-918. doi: 10.1038/s41591-020-0839-y. Epub 2020 May 29.
7
TIMER2.0 for analysis of tumor-infiltrating immune cells.TIMER2.0 用于分析肿瘤浸润免疫细胞。
Nucleic Acids Res. 2020 Jul 2;48(W1):W509-W514. doi: 10.1093/nar/gkaa407.
8
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy.肿瘤微环境中的免疫细胞:在癌症免疫治疗中的生物学功能和作用。
Cancer Lett. 2020 Feb 1;470:126-133. doi: 10.1016/j.canlet.2019.11.009. Epub 2019 Nov 12.
9
The Tumor Microenvironment Innately Modulates Cancer Progression.肿瘤微环境先天调节癌症进展。
Cancer Res. 2019 Sep 15;79(18):4557-4566. doi: 10.1158/0008-5472.CAN-18-3962. Epub 2019 Jul 26.
10
Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis.人类 DEF6 缺陷是一种免疫缺陷综合征的基础,其特征是全身自身免疫和 CTLA-4 稳态异常。
Nat Commun. 2019 Jul 15;10(1):3106. doi: 10.1038/s41467-019-10812-x.